The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Increased poly(ADP-ribosyl)ation of nuclear proteins in Alzheimer's disease
Open accessAbstract
Experimental studies indicate that overactivation of the DNA repair protein poly(ADP-ribose) polymerase (PARP) in response to oxidative damage to DNA can cause cell death due to depletion of NAD+. Oxidative damage to DNA and other macromolecules has been reported to be increased in the brains of patients with Alzheimer's disease. In the present study we sought evidence of PARP activation in Alzheimer's disease by immunostaining sections of frontal and temporal lobe from autopsy material of 20 patients and 10 controls, both for PARP itself and for its end-product, poly(ADP-ribose). All of the brains had previously been subjected to detailed neuropathological examination to confirm the diagnosis of Alzheimer's disease or, in the controls, to exclude Alzheimer's disease-type pathology. Double immunolabelling for poly(ADP-ribose) and microtubule-associated protein 2 (MAP2), glial fibrillary-acidic protein (GFAP), CD68, A beta-protein or tau was used to assess the identity of the cells with poly(ADP-ribose) accumulation and their relationship to plaques and neurofibrillary tangles. Both PARP- and poly(ADP-ribose)-immunolabelled cells were detected in a much higher proportion of Alzheimer's disease (20 out of 20) brains than of control brains (5 out of 10) (P = 0.0018). Double-immunolabelling for poly(ADP-ribose) and markers of neuronal, astrocytic and microglial differentiation (MAP2, GFAP and CD68, respectively) showed many of the cells containing poly(ADP-ribose) to be neurons. Most of these were small pyramidal neurons in cortical laminae 3 and 5. A few of the cells containing poly(ADP-ribose) were astrocytes. No poly(ADP-ribose) accumulation was detected in microglia. Double-immunolabelling for poly(ADP-ribose) and tau or A beta-protein indicated that the cells with accumulation of poly(ADP-ribose) did not contain tangles and relatively few occurred within plaques. Our findings indicate that there is enhanced PARP activity in Alzheimer's disease and suggest that pharmacological interventions aimed at inhibiting PARP may have a role in slowing the progression of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G. G., & Heyman, A. (2002) · Principles and Practice of Geriatric Psychiatry · doi:10.1002/0470846410.ch42(iii · Cited by 2,410
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Role of poly(ADP-ribose) formation in DNA repair
Satoh, M. S., & Lindahl, T. (1992) · Nature · doi:10.1038/356356a0 · Cited by 1,174
Nitric Oxide Activation of Poly(ADP-Ribose) Synthetase in Neurotoxicity
Zhang, J., Dawson, V. L., Dawson, T. M., & Snyder, S. H. (1994) · Science · doi:10.1126/science.8080500 · Cited by 1,118
Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells
de Murcia, J. M., Niedergang, C., Trucco, C., Ricoul, M., Dutrillaux, B., Mark, M., Oliver, F. J., Masson, M., Dierich, A., LeMeur, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7303 · Cited by 1,056
Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia
Eliasson, M. J. L., Sampei, K., Mandir, A. S., Hurn, P. D., Traystman, R. J., Bao, J., Pieper, A., Wang, Z.-Q., Dawson, T. M., Snyder, S. H., et al. (1997) · Nature Medicine · doi:10.1038/nm1097-1089 · Cited by 1,018
Sayre, L. M., Zelasko, D. A., Harris, P. L. R., Perry, G., Salomon, R. G., & Smith, M. A. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052092.x · Cited by 1,007
Hensley, K., Hall, N., Subramaniam, R., Cole, P., Harris, M., Aksenov, M., Aksenova, M., Gabbita, S. P., Wu, J. F., Carney, J. M., et al. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65052146.x · Cited by 779
Evidence of neuronal oxidative damage in Alzheimer's disease.
Good, P. F., Werner, P., Hsu, A., Olanow, C. W., & Perl, D. P. (1996) · Europe PMC (PubMed Central) · Cited by 663
Ischemic Brain Injury is Mediated by the Activation of Poly(ADP-Ribose)Polymerase
Endres, M., Wang, Z.-Q., Namura, S., Waeber, C., & Moskowitz, M. A. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199711000-00002 · Cited by 622
Szabó, C., Zingarelli, B., O'Connor, M., & Salzman, A. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.1753 · Cited by 622
Immunohistochemical evidence for apoptosis in Alzheimerʼs disease
Su, J. H., Anderson, A. J., Cummings, B. J., & Cotman, C. W. (1994) · NeuroReport · doi:10.1097/00001756-199412000-00031 · Cited by 571
Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress.
Yan, S. D., Chen, X., Schmidt, A. M., Brett, J., Godman, G., Zou, Y. S., Scott, C. W., Caputo, C., Frappier, T., & Smith, M. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7787 · Cited by 565
Lyras, L., Cairns, N. J., Jenner, A., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052061.x · Cited by 531
Radical AGEing in Alzheimer's disease
Smith, M. A., Sayre, L. M., Monnier, V. M., & Perry, G. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93897-7 · Cited by 462
Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ
Lassmann, H., Bancher, C., Breitschopf, H., Wegiel, J., Bobinski, M., Jellinger, K., & Wisniewski, H. M. (1995) · Acta Neuropathologica · doi:10.1007/bf00294257 · Cited by 458
DNA Damage Induced by Peroxynitrite: Subsequent Biological Effects
Szabó, C., & Ohshima, H. (1997) · Nitric Oxide · doi:10.1006/niox.1997.0143 · Cited by 443
Keller, J. N., Pang, Z., Geddes, J. W., Begley, J. G., Germeyer, A., Waeg, G., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010273.x · Cited by 439
Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease.
Smith, M. A., Kutty, R. K., Richey, P. L., Yan, S. D., Stern, D., Chader, G. J., Wiggert, B. O., Petersen, R. B., & Perry, G. L. (1994) · PubMed · Cited by 424
Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists.
Mirra, S. S., Hart, M. N., & Terry, R. D. (1993) · PubMed · Cited by 415
Chapter 6 Glutamate receptors and the induction of excitotoxic neuronal death
Choi, D. W. (1994) · Progress in Brain Research · doi:10.1016/s0079-6123(08)60767-0 · Cited by 385
Pappolla, M. A., Chyan, Y., Omar, R. A., Hsiao, K., Perry, G. L., Smith, M. A., & Bozner, P. (1998) · Europe PMC (PubMed Central) · Cited by 365
Are reactive oxygen species involved in Alzheimer's disease?
Benzi, G. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00066-n · Cited by 365
Expression of heme oxygenase‐1 in the senescent and alzheimer‐diseased brain
Schipper, H. M., Cissé, S., & Stopa, E. G. (1995) · Annals of Neurology · doi:10.1002/ana.410370609 · Cited by 356
Dragunow, M., Faull, R. L. M., Lawlor, P., Beilharz, E. J., Singleton, K., Walker, E. B., & Mee, E. (1995) · NeuroReport · doi:10.1097/00001756-199505090-00026 · Cited by 342
Harris, M. E., Hensley, K., Butterfield, D. A., Leedle, R. A., & Carney, J. M. (1995) · Experimental Neurology · doi:10.1016/0014-4886(95)90041-1 · Cited by 332
Monoclonal antibodies to poly(adenosine diphosphate ribose) recognize different structures
Kawamitsu, H., Hoshino, H., Okada, H., Miwa, M., Momoi, H., & Sugimura, T. (1984) · Biochemistry · doi:10.1021/bi00311a032 · Cited by 232
Neuroprotective Effects of Inhibiting Poly(ADP-Ribose) Synthetase on Focal Cerebral Ischemia in Rats
Takahashi, K., Greenberg, J. H., Jackson, P., Maclin, K., & Zhang, J. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199711000-00001 · Cited by 158
Amyloid β-peptide and oxidative cellular injury in Alzheimer’s disease
Mark, R. J., Blanc, E. M., & Mattson, M. P. (1996) · Molecular Neurobiology · doi:10.1007/bf02755589 · Cited by 146
A Population Based Strategy to Prevent Insulin-Dependent Diabetes Using Nicotinamide
Elliott, R. B., Pilcher, C. C., Fergusson, D. M., & Stewart, A. W. (1996) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.1996.9.5.501 · Cited by 99
Troncoso, J. C., Sukhov, R. R., Kawas, C. H., & Koliatsos, V. E. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199611000-00004 · Cited by 96
Meta-Analysis of Nicotinamide Treatment in Patients With Recent-Onset IDDM
Pozzilli, P., Browne, P., Kolb, H., & Trialists, T. N. (1996) · Diabetes Care · doi:10.2337/diacare.19.12.1357 · Cited by 95
The Diagnosis of Alzheimer's Disease
Villareal, D. T., & Morris, J. C. (1999) · Journal of Alzheimer s Disease · doi:10.3233/jad-1999-14-506 · Cited by 87
The effect of niacinamide on osteoarthritis: A pilot study
Jonas, W. B., Rapoza, C. P., & Blair, W. F. (1996) · Inflammation Research · doi:10.1007/bf02252945 · Cited by 86
Birkmayer, J. G. D. (1996) · PubMed · Cited by 77
Neuronal accumulation of poly(ADP‐ribose) after brain ischaemia
Love, S., Barber, & Wilcock (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00179.x · Cited by 75
Self-citationDouble blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study)
Pozzilli, P., Visalli, N., Signore, A., Baroni, M. G., Buzzetti, R., Cavallo, M. G., Boccuni, M. L., Fava, D., Gragnoli, C., Andreani, D., et al. (1995) · Diabetologia · doi:10.1007/s001250050362 · Cited by 75
Apoptosis and expression of DNA repair proteins in ischaemic brain injury in man
Love, S., Barber, R., & Wilcock, G. K. (1998) · Neuroreport · doi:10.1097/00001756-199804200-00001 · Cited by 60
Self-citationPozzilli, P., Visalli, N., Cavallo, M. G., Signore, A., Baroni, M. G., Buzzetti, R., Fioriti, E., Mesturino, C. A., Fiori, R., Romiti, A., et al. (1997) · European Journal of Endocrinology · doi:10.1530/eje.0.1370234 · Cited by 56
Weinfeld, M., Chaudhry, M. A., D’Amours, D., Pelletier, J. D., Poirier, G. G., Povirk, L. F., Lees‐Miller, S. P., & Pelletier, J. D. (1997) · Radiation Research · doi:10.2307/3579534 · Cited by 55
Molecular Mechanisms of Beta-Cell Destruction in IDDM The Role of Nicotinamide
Gale, E. A. (2008) · Hormone Research · doi:10.1159/000184828 · Cited by 45
Lautier, D., Poirier, D., Boudreau, A. C., et al. (1990) · Biochemistry and Cell Biology · doi:10.1139/o90-085 · Cited by 26
Cited by
Apoptosis: A Review of Programmed Cell Death
Elmore, S. (2007) · Toxicologic Pathology · doi:10.1080/01926230701320337 · Cited by 13,853
The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
Virág, L., & Szabó, C. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.3.375 · Cited by 1,373
Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide
Butterfield, D. A., Drake, J., Pocernich, C., & Castegna, A. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02173-6 · Cited by 1,114
Kruman, I. I., Kumaravel, T. S., Lohani, A., Pedersen, W. A., Cutler, R. G., Kruman, Y., Haughey, N., Lee, J., Evans, M., & Mattson, M. P. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01752.2002 · Cited by 643
Parthanatos: mitochondrial‐linked mechanisms and therapeutic opportunities
Fatokun, A. A., Dawson, V. L., & Dawson, T. M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12416 · Cited by 594
Metadata
- Authors
- Love, S., Barber, R., & Wilcock, G. K.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-02
- Volume
- 122
- Issue
- 2
- Pages
- 247-253
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2151861142
- Cited by
- 254
- References
- 43
- FWCI
- 3.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.